Integrated Core Strategies (US) LLC 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-09 4:26 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
Integrated Core Strategies (US) LLC | 967,402 2.700% |
-1,123,431 (-53.73%) |
Filing |
| 2023-10-24 4:12 pm Purchase |
2023-10-17 | 13G | iTeos Therapeutics, Inc. ITOS |
Integrated Core Strategies (US) LLC | 2,090,833 5.800% |
2,090,833 (New Position) |
Filing |